vs
Cooper Companies (The)（COO）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是SCANSOURCE, INC.的1.4倍（$1.1B vs $766.5M），Cooper Companies (The)净利率更高（7.9% vs 2.2%，领先5.8%），Cooper Companies (The)同比增速更快（4.6% vs 2.5%），Cooper Companies (The)自由现金流更多（$149.9M vs $28.9M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 0.9%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
COO vs SCSC — 直观对比
营收规模更大
COO
是对方的1.4倍
$766.5M
营收增速更快
COO
高出2.0%
2.5%
净利率更高
COO
高出5.8%
2.2%
自由现金流更多
COO
多$121.0M
$28.9M
两年增速更快
COO
近两年复合增速
0.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $766.5M |
| 净利润 | $84.6M | $16.5M |
| 毛利率 | 61.1% | 13.4% |
| 营业利润率 | 13.2% | 2.3% |
| 净利率 | 7.9% | 2.2% |
| 营收同比 | 4.6% | 2.5% |
| 净利润同比 | -28.0% | -3.3% |
| 每股收益（稀释后） | $0.42 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOSCSC
| Q4 25 | $1.1B | $766.5M | ||
| Q3 25 | $1.1B | $739.6M | ||
| Q2 25 | $1.0B | $812.9M | ||
| Q1 25 | $964.7M | $704.8M | ||
| Q4 24 | $1.0B | $747.5M | ||
| Q3 24 | $1.0B | $775.6M | ||
| Q2 24 | $942.6M | $746.1M | ||
| Q1 24 | $931.6M | $752.6M |
净利润COOSCSC
| Q4 25 | $84.6M | $16.5M | ||
| Q3 25 | $98.3M | $19.9M | ||
| Q2 25 | $87.7M | $20.1M | ||
| Q1 25 | $104.3M | $17.4M | ||
| Q4 24 | $117.5M | $17.1M | ||
| Q3 24 | $104.7M | $17.0M | ||
| Q2 24 | $88.9M | $16.1M | ||
| Q1 24 | $81.2M | $12.8M |
毛利率COOSCSC
| Q4 25 | 61.1% | 13.4% | ||
| Q3 25 | 65.3% | 14.5% | ||
| Q2 25 | 67.8% | 12.9% | ||
| Q1 25 | 68.4% | 14.2% | ||
| Q4 24 | 66.5% | 13.6% | ||
| Q3 24 | 66.1% | 13.1% | ||
| Q2 24 | 67.0% | 13.0% | ||
| Q1 24 | 67.0% | 12.6% |
营业利润率COOSCSC
| Q4 25 | 13.2% | 2.3% | ||
| Q3 25 | 16.6% | 3.5% | ||
| Q2 25 | 18.4% | 3.3% | ||
| Q1 25 | 18.9% | 3.2% | ||
| Q4 24 | 19.5% | 2.5% | ||
| Q3 24 | 19.2% | 2.3% | ||
| Q2 24 | 17.2% | 2.9% | ||
| Q1 24 | 16.4% | 2.3% |
净利率COOSCSC
| Q4 25 | 7.9% | 2.2% | ||
| Q3 25 | 9.3% | 2.7% | ||
| Q2 25 | 8.7% | 2.5% | ||
| Q1 25 | 10.8% | 2.5% | ||
| Q4 24 | 11.5% | 2.3% | ||
| Q3 24 | 10.4% | 2.2% | ||
| Q2 24 | 9.4% | 2.2% | ||
| Q1 24 | 8.7% | 1.7% |
每股收益（稀释后）COOSCSC
| Q4 25 | $0.42 | $0.75 | ||
| Q3 25 | $0.49 | $0.89 | ||
| Q2 25 | $0.44 | $0.87 | ||
| Q1 25 | $0.52 | $0.74 | ||
| Q4 24 | $0.59 | $0.70 | ||
| Q3 24 | $0.52 | $0.69 | ||
| Q2 24 | $0.44 | $0.66 | ||
| Q1 24 | $0.41 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $83.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $8.2B | $910.9M |
| 总资产 | $12.4B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资COOSCSC
| Q4 25 | $110.6M | $83.5M | ||
| Q3 25 | $124.9M | $124.9M | ||
| Q2 25 | $116.2M | $126.2M | ||
| Q1 25 | $100.9M | $146.3M | ||
| Q4 24 | $107.6M | $110.5M | ||
| Q3 24 | $109.7M | $145.0M | ||
| Q2 24 | $112.4M | $185.5M | ||
| Q1 24 | $135.2M | $159.1M |
总债务COOSCSC
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益COOSCSC
| Q4 25 | $8.2B | $910.9M | ||
| Q3 25 | $8.4B | $914.0M | ||
| Q2 25 | $8.3B | $906.4M | ||
| Q1 25 | $8.1B | $901.7M | ||
| Q4 24 | $8.1B | $900.7M | ||
| Q3 24 | $7.9B | $920.9M | ||
| Q2 24 | $7.8B | $924.3M | ||
| Q1 24 | $7.7B | $944.1M |
总资产COOSCSC
| Q4 25 | $12.4B | $1.7B | ||
| Q3 25 | $12.4B | $1.7B | ||
| Q2 25 | $12.4B | $1.8B | ||
| Q1 25 | $12.2B | $1.7B | ||
| Q4 24 | $12.3B | $1.7B | ||
| Q3 24 | $12.1B | $1.8B | ||
| Q2 24 | $12.0B | $1.8B | ||
| Q1 24 | $12.0B | $1.8B |
负债/权益比COOSCSC
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $28.9M |
| 自由现金流率自由现金流/营收 | 14.1% | 3.8% |
| 资本支出强度资本支出/营收 | 9.2% | 0.3% |
| 现金转化率经营现金流/净利润 | 2.93× | 1.87× |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOSCSC
| Q4 25 | $247.9M | $30.8M | ||
| Q3 25 | $261.4M | $23.2M | ||
| Q2 25 | $96.2M | — | ||
| Q1 25 | $190.6M | $66.1M | ||
| Q4 24 | $268.1M | $-6.2M | ||
| Q3 24 | $207.5M | $44.8M | ||
| Q2 24 | $111.0M | — | ||
| Q1 24 | $122.7M | $160.2M |
自由现金流COOSCSC
| Q4 25 | $149.9M | $28.9M | ||
| Q3 25 | $164.5M | $20.8M | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | $64.6M | ||
| Q4 24 | $128.1M | $-8.2M | ||
| Q3 24 | $118.5M | $42.5M | ||
| Q2 24 | $36.9M | — | ||
| Q1 24 | $4.6M | $157.7M |
自由现金流率COOSCSC
| Q4 25 | 14.1% | 3.8% | ||
| Q3 25 | 15.5% | 2.8% | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | 9.2% | ||
| Q4 24 | 12.6% | -1.1% | ||
| Q3 24 | 11.8% | 5.5% | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 0.5% | 21.0% |
资本支出强度COOSCSC
| Q4 25 | 9.2% | 0.3% | ||
| Q3 25 | 9.1% | 0.3% | ||
| Q2 25 | 7.8% | 0.3% | ||
| Q1 25 | 9.3% | 0.2% | ||
| Q4 24 | 13.7% | 0.3% | ||
| Q3 24 | 8.9% | 0.3% | ||
| Q2 24 | 7.9% | 0.2% | ||
| Q1 24 | 12.7% | 0.3% |
现金转化率COOSCSC
| Q4 25 | 2.93× | 1.87× | ||
| Q3 25 | 2.66× | 1.17× | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.83× | 3.79× | ||
| Q4 24 | 2.28× | -0.36× | ||
| Q3 24 | 1.98× | 2.64× | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.51× | 12.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
